0001209191-20-016928.txt : 20200306
0001209191-20-016928.hdr.sgml : 20200306
20200306163146
ACCESSION NUMBER: 0001209191-20-016928
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200305
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Breeden Richard C
CENTRAL INDEX KEY: 0001300622
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38848
FILM NUMBER: 20695212
MAIL ADDRESS:
STREET 1: 100 SOUTH WACKER
STREET 2: SUITE 1800
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STERIS plc
CENTRAL INDEX KEY: 0001757898
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 35312322000
MAIL ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: STERIS Ltd
DATE OF NAME CHANGE: 20181101
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-05
0
0001757898
STERIS plc
STE
0001300622
Breeden Richard C
C/O 70 SIR JOHN ROGERSON'S QUAY
DUBLIN
L2
2
IRELAND
1
0
0
0
Ordinary Shares
2020-03-05
4
M
0
3133
32.34
A
31681
D
Ordinary Shares
72242
I
See Footnote Below.
Director Stock Option (right to buy)
32.34
2020-03-05
4
M
0
3133
0.00
D
2020-08-04
Ordinary Shares
3133
0
D
Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund").
Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares.
This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
2020-03-05